Literature DB >> 4557341

Lipid patterns of leukocytes in health and disease.

E L Gottfried.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4557341

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  7 in total

1.  In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.

Authors:  Martin Schmidt-Hieber; Robert Dabrowski; Andreas Weimann; Babette Aicher; Philipp Lohneis; Antonia Busse; Eckhard Thiel; Igor W Blau
Journal:  Invest New Drugs       Date:  2010-11-16       Impact factor: 3.850

2.  Changes in lipid ordering and state of aggregation in lymphocyte plasma membranes after exposure to mitogens.

Authors:  C C Curtain; F D Looney; J J Marchalonis; J K Raison
Journal:  J Membr Biol       Date:  1978-12-29       Impact factor: 1.843

3.  Comparative study of the glycosphingolipids of chicken bursa of Fabricius and of chicken, rat and human thymus.

Authors:  R Narasimhan; R K Murray
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

4.  Ether lipid content and fatty acid distribution in rabbit polymorphonuclear neutrophil phospholipids.

Authors:  H W Mueller; J T O'Flaherty; R L Wykle
Journal:  Lipids       Date:  1982-02       Impact factor: 1.880

5.  Leukocyte dysfunction in the bovine homologue of the Chediak-Higashi syndrome of humans.

Authors:  H W Renshaw; W C Davis; H H Fudenberg; G A Padgett
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

6.  Protein content, dry mass and chemical composition of individual mast cells related to body growth.

Authors:  L Mellblom; L Enerbäck
Journal:  Histochemistry       Date:  1979-09

7.  Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.

Authors:  V C Pratt; S Watanabe; E Bruera; J Mackey; M T Clandinin; V E Baracos; C J Field
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.